Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-252-4 | CAS number: 56539-66-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-12-04 to 2013-01-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Qualifier:
- according to guideline
- Guideline:
- other: - OECD Environmental Health and Safety Publications, Series on Testing and Assessment no. 28. Guidance document for the conduct of skin absorption studies (March 2004).
- Qualifier:
- according to guideline
- Guideline:
- other: - OECD Guidance Notes on Dermal absorption, Draft 22 October 2010
- Qualifier:
- according to guideline
- Guideline:
- other: - European Commission Guidance Document on Dermal Absorption – Sanco/222/2000/Rev. 7 (19 March 2004)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 3-Methoxy-3-methyl-1-butanol
- IUPAC Name:
- 3-Methoxy-3-methyl-1-butanol
- Reference substance name:
- 3-methoxy-3-methylbutan-1-ol
- EC Number:
- 260-252-4
- EC Name:
- 3-methoxy-3-methylbutan-1-ol
- Cas Number:
- 56539-66-3
- Molecular formula:
- C6H14O2
- IUPAC Name:
- 3-methoxy-3-methylbutan-1-ol
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): 3-Methoxy-3-methyl-1-butanol
- Molecular formula (if other than submission substance): C6H14O2
- Molecular weight (if other than submission substance): 118.14
- Physical state: Clear colourless liquid (determined at WIL Research Europe B.V.)
- Analytical purity: 99.47%
- Lot/batch No.: 32726
- Expiration date of the lot/batch: 30 June 2013
- Stability under storage conditions: Stable
- Storage condition of test material: At room temperature in the dark
- Other:
Study specific test substance information:
- Purity/composition correction factor required: No
- Hygroscopic: Yes, store in well-sealed container
- Volatile: Yes, vapour pressure: 47 Pa at 293K
- Density: 0.927 g/cm3 (20°C)
- Stability in vehicle: Water: Yes
- Solubility in vehicle: Water: Miscible
3-Methyl-3-methoxy [4-14C]butan-1-ol (substance 204543/A)
- Identification: 3-Methyl-3-methoxy-[4-14C]1-butanol
- Molecular formula: C6H14O2
- Molecular weight: 119.85 (at this specific activity)
- Description: Solution in acetonitrile
- Batch: 7047CDB026-6
- Radiochemical purity: 98.5%
- Chemical purity: Not indicated
- Test substance storage: In freezer (= -15°C) in the dark
- Expiry date: 30 November 2013 (allocated by WIL Research Europe B.V., 1 year after receipt of the test substance)
- Specific activity: 16.10 MBq/mg (1930 MBq/mmol)
- Radioactive concentration: 24.76 MBq/mL
- Total activity: 111.6 MBq
- Supplier: Selcia Limited, Fyfield Business and Research Park, Fyfield Road, Ongar, Essex, CM5 0GS, UK
[3H]-H2O (180603/E):
- Identification: Water [3H] (biological grade)
- Molecular formula: H2O
- Molecular weight: 18
- Description: Clear solution
- Batch: 110511
- Test substance storage: In refrigerator (2-8°C) in the dark
- Expiry date: 21 October 2013 (allocated by WIL Research Europe, 1 year after receipt of the test substance)
- Concentration: 1 mCi/mL (37 MBq/mL)
- Total activity: 5 mCi (185 MBq) (taken from label)
- Supplier: American Radiolabeled Chemicals, Inc., 101 ARC Drive, Saint Louis, MO 63146 USA
Constituent 1
Constituent 2
- Radiolabelling:
- yes
Test animals
- Species:
- human
- Strain:
- not specified
- Sex:
- not specified
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- water
- Duration of exposure:
- 24 h
- Doses:
- undiluted (100%) mixed with 3-Methyl-3-methoxy[4-14C]butan-1-ol
aqueous dilution (10%) mixed with 3-Methyl-3-methoxy[4-14C]butan-1-ol - Details on study design:
- Human skin was placed into flow-through cells and exposed to 3-Methoxy-3-methyl-1-butanol for 24 hours under occlusion conditions. The receptor fluid was collected at various time points. At the end of the experiments the amount of radioactivity was determined at the donor site, in the skin (tape-stripping and total skin) and in the receptor fluid. Prior to the determination of the dermal absorption of 3-Methoxy-3-methyl-1-butanol, the skin integrity was checked by determination of the permeation of tritiated water.
- Justification of species, anatomical site and preparative technique: Human skin is a recommended test system forin vitroskin absorption studies. - Details on in vitro test system (if applicable):
- - Flow-through system: The skin penetration study was performed on a flow-through cell system consisting of :
peristaltic pump; 13 flow-through cells, diameter 9 mm (Permegear, Bethlehem, PA, USA), fraction collector and thermostat.
- Alliance HT Separations module 2795 liquid chromatograph and a
- Radio-Detector:ß-RAM Model 4 (Lablogic, Sheffield, England).
The receptor fluid was pumped at a flow rate of 1.5 mL/h.
- Test temperature: The skin surface temperature was 32±1ºC
- Humidity: ambient humidity (30-70%)
- Occlusion: yes
Results and discussion
- Signs and symptoms of toxicity:
- not examined
- Dermal irritation:
- not examined
- Absorption in different matrices:
- The receptor fluid consisted of saline (0.9% NaCl solution); donor chamber was occluded during the exposure.
A maximum solute flux of 0.055mg/cm²/h for the pure MMB and 0.113 mg/cm²/h for the 10% aqueous solution was determined. - Total recovery:
- Undiluted sample (100%): 84 +- 11%
Aqueous dilution (10%) : 80 +-4%
Percutaneous absorptionopen allclose all
- Dose:
- 10%
- Parameter:
- percentage
- Absorption:
- 33 %
- Remarks on result:
- other: 4h
- Remarks:
- lag time 2h
- Dose:
- 10%
- Parameter:
- percentage
- Absorption:
- 40 %
- Remarks on result:
- other: 24h
- Remarks:
- lag time 2h
- Dose:
- 100%
- Parameter:
- percentage
- Absorption:
- 4 %
- Remarks on result:
- other: 8h
- Remarks:
- lag time 2.5h
- Dose:
- 100%
- Parameter:
- percentage
- Absorption:
- 6.9 %
- Remarks on result:
- other: 24h
- Remarks:
- lag time 2.5h
Any other information on results incl. tables
Radiochemical purity:
The radiochemical purity of a stock solution of3-Methyl-3-methoxy[4-14C]butan-1-olin 0.1% TFA in MQ/Acetonitrile (1:1, v/v) was determined at the start of the study. The radiochemical purity was 98.9% and 99.3% (based on two independent injections), which was above the required 97%.
Homogeneity of test substance samples mixed with 3-Methyl-3-methoxy[4-14C]butan-1-ol:
The results of the homogeneity check of the formulations mixed with 3-Methyl-3-methoxy[4-14C]butan-1-olare presented inTable 2. The relative standard deviations from samples taken from the top, middle and bottom of the vial were below 3% and thus all formulations were homogeneous.
Table 2: Results of homogeneity check of formulations
Formulation |
Activity (MBq/mL) |
Subsample counted (mL) |
Activity (dpm) |
MBq/mL |
Undiluted (100%) |
2.1 |
0.005 |
T: 631078 M: 623856 B: 606871 |
2.104 2.080 2.023 |
|
|
|
Average RSD |
2.1 2.0% |
|
2.0 |
0.010 |
T: 1207028 M: 1197346 B: 1203662 |
2.012 1.996 2.006 |
|
|
|
Average RSD |
2.0 0.4% |
Aqueous dilution (10%) |
1.9 |
0.005 |
T: 580451 M: 572013 B: 551076 |
1.935 1.907 1.837 |
|
|
|
Average RSD |
1.9 2.7 % |
|
2.0 |
0.010 |
T: 1198504 M: 1213581 B: 1231184 |
1.998 2.023 2.052 |
|
|
|
Average RSD |
2.0 1.3% |
RSD: relative standard deviation
Table 3: Results of the solubility test in the receptor fluid
Formulation |
Expected activity in receptor fluid |
Actual activity in receptor fluid |
||||||
Dose (g/L) |
Activity (MBq/mL) |
Volume formulation applied (µL) |
Volume receptor fluid (mL) |
Activity (kBq/mL) |
Subsample counted (mL) |
(DPM) |
(kBq/mL) |
Recovery (%)1) |
0.922 |
2.1 |
6.4 |
36 |
0.368 |
1.0 |
23365 |
0.389 |
106 |
|
|
|
1.0 |
23353 |
0.389 |
106 |
||
|
|
|
1.0 |
23266 |
0.388 |
105 |
||
|
|
|
|
|
Average |
0.389 |
106 |
|
|
|
|
|
SD |
0.0009 |
|
||
|
|
|
|
RSD |
0.23% |
|
1) ratio of activity in receptor fluid solution and the activity of formulation in receptor fluid, multiplied by 100
Skin integrity:
The permeability coefficients for tritiated water for the skin discs that have been used for this study are presented inTable 4. The integrity of the reported skin discs was within the acceptability criteria (Kp< 4.5 x 10-3cm/h).
Table 4: Skin integrity values
Test substance sample |
Skin disc (donor number-disc number) |
|||||
Kp value for tritiated water (*10-3cm/h) |
||||||
undiluted (100%) |
2796-03 |
2824-08 |
2796-04 |
2824-11 |
2825-04 |
2830-04 |
3.80 |
1.93 |
4.02 |
1.90 |
2.15 |
3.13 |
|
Aqueous dilution (10%) |
2825-01 |
2830-01 |
2832-05 |
2830-05 |
|
|
2.75 |
3.58 |
3.49 |
2.97 |
|
|
Table 5: Dermal absorption parameters and percentage absorption of 3-Methoxy-3-methyl-1-butanol in human skinin vitro
Formulation |
Undiluted 100% (0.922 g/mL) |
Aqueous dilution 10% (0.092 g/mL) |
||
Skin samples |
human (n=6) |
human (n=4) |
||
% RAD1) |
SD2) |
% RAD1) |
SD2) |
|
DERMAL ABSORPTION PARAMETERS |
|
|
|
|
Lag time (h) |
1-3 |
|
1-2 |
|
Maximum flux (µg/cm2/h) |
0.055 |
0.018 |
0.113 |
0.020 |
SURFACE COMPARTMENT |
|
|
|
|
Total skin swabs 24 h |
0.16 |
0.08 |
0.73 |
0.55 |
Material remaining in donor chamber |
77 |
12 |
39 |
4 |
Total % non-absorbed3) |
78 |
12 |
40 |
4 |
SKIN COMPARTMENT |
|
|
|
|
Skin |
0.09 |
0.04 |
0.35 |
0.06 |
Tape strips 1&2 |
0.01 |
0.01 |
0.005 |
0.004 |
Stratum corneum (tape strips excluding 1&2) |
0.03 |
0.01 |
0.03 |
0.01 |
Total % at dose site (without tape strips 1&2) |
0.13 |
0.04 |
0.38 |
0.06 |
RECEPTOR COMPARTMENT |
|
|
|
|
Receptor fluid (collected over 24 h) |
7 |
2 |
40 |
1 |
Receptor fluid terminal |
0.03 |
0.01 |
0.04 |
0.03 |
Receptor chamber |
0.03 |
0.02 |
0.07 |
0.07 |
Total % directly absorbed4) |
7 |
2 |
40 |
1 |
OVERALL ABSORPTION |
|
|
|
|
Total % potentially absorbable (without tape strips 1&2)5) |
7 |
2 |
40 |
1 |
Total % recovery |
84 |
11 |
80 |
4 |
1)RAD = radioactivity
2) SD= Standard deviation
3)Total % non-absorbed = % in total skin swabs 24 h + % material remaining in donor chamber
4)Total % directly absorbed = % receptor fluid + % receptor fluid terminal + % receptor chamber
5)Total % potentially absorbable (without tape strips 1&2) = Total % at dose site (without tape strips 1&2) + total % directly absorbed
Applicant's summary and conclusion
- Conclusions:
- The in vitro dermal absorption of human skin with 3-Methoxy-3-methyl-1-butanol was 7 ± 2% for the undiluted substance and 40 ± 1%.for the 10% aqueous solution over a penetration time of 24 hours. A maximum solute flux of 0.055mg/cm²/h for the pure MMB and 0.113 mg/cm²/h for the 10% aqueous solution was determined.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.